Submitted by Anonymous (not verified) on 22 April 2026 - 14:40
Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 21, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 21, Status: Authorised